drugset / Trial / NCT00373620

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients

NCT00373620 ↗

Phase 2 Unknown 50 enrolled Korean Gynecologic Oncology Group
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether post-operative concurrent chemoradiation with paclitaxel is effective and safe in the treatment of high risk postoperative endometrial cancer patients.

Timeline

Start
2006-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 60 mg/m2 —

Indications